Recent advances in the search for new anti-coccidial drugs.
Coccidia provide a rich hunting ground for drug-designers, as there are significant biochemical differences between the parasites and their hosts. Recent years have brought the discovery of the plastid and its possible metabolic machinery, characterisation of acidocalcisomes, reports on the apparent absence from some coccidia of a typical mitochondrion, and the discovery of the mannitol cycle and shikimate pathway in the parasites. Moreover, modern technologies such as genomics and proteomics are bringing new insights into the biochemistry of coccidia and highlighting possible drug targets in abundance. A major issue for would-be drug discoverers is to decide upon the targets to prioritise. This review provides an update on recent findings on how coccidia differ biochemically from vertebrates. It includes discoveries within coccidian parasites themselves but also uses findings in Plasmodium to provide an overview of biochemical features that may be characteristics of many apicomplexan parasites and so potential targets for broad-spectrum drugs.
Coombs
G H
GH
Division of Infection and Immunity, Institute of Biomedical and Life Sciences, Joseph Black Building, University of Glasgow, G12 8QQ, Glasgow, UK. g.coombs@bio.gla.ac.uk
Müller
S
S
D000818:Animals; D003044:Coccidia / Q000187:drug effects* / Q000378:metabolism*; D003048:Coccidiosis / Q000188:drug therapy*; D003049:Coccidiostats / Q000494:pharmacology / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D018087:Plastids / Q000187:drug effects
D003049:Coccidiostats